BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 26137590)

  • 21. Stimulatory Effects of Mesenchymal Stem Cells on cKit+ Cardiac Stem Cells Are Mediated by SDF1/CXCR4 and SCF/cKit Signaling Pathways.
    Hatzistergos KE; Saur D; Seidler B; Balkan W; Breton M; Valasaki K; Takeuchi LM; Landin AM; Khan A; Hare JM
    Circ Res; 2016 Sep; 119(8):921-30. PubMed ID: 27481956
    [TBL] [Abstract][Full Text] [Related]  

  • 22. cKit+ cardiac progenitors of neural crest origin.
    Hatzistergos KE; Takeuchi LM; Saur D; Seidler B; Dymecki SM; Mai JJ; White IA; Balkan W; Kanashiro-Takeuchi RM; Schally AV; Hare JM
    Proc Natl Acad Sci U S A; 2015 Oct; 112(42):13051-6. PubMed ID: 26438843
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mesenchymal stem cell treatment for hemophilia: a review of current knowledge.
    Sokal EM; Lombard C; Mazza G
    J Thromb Haemost; 2015 Jun; 13 Suppl 1():S161-6. PubMed ID: 26149017
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Generation of cardiac spheres from primate pluripotent stem cells in a small molecule-based 3D system.
    Jiang B; Xiang Z; Ai Z; Wang H; Li Y; Ji W; Li T
    Biomaterials; 2015 Oct; 65():103-14. PubMed ID: 26148474
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mesenchymal stromal cells and rheumatic disorders.
    Tyndall A
    Immunol Lett; 2015 Dec; 168(2):201-7. PubMed ID: 26142543
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endothelial progenitor cells: Cardiovascular protection in Parkinson's disease?
    Pezzoli G; Cavanna F; Cassani E; Barichella M; Pinelli G; Iorio L; Pusani C; Canesi M; Natuzzi F; Cazzola R; Cestaro B; Cereda E
    Int J Cardiol; 2015 Oct; 197():200-2. PubMed ID: 26142206
    [No Abstract]   [Full Text] [Related]  

  • 27. Novel role of bone marrow stem cells in systemic disease.
    Penn MS; Swaminath D
    Circ Res; 2015 Jul; 117(2):119-20. PubMed ID: 26139857
    [No Abstract]   [Full Text] [Related]  

  • 28. N-Cadherin Overexpression Mobilizes the Protective Effects of Mesenchymal Stromal Cells Against Ischemic Heart Injury Through a β-Catenin-Dependent Manner.
    Yan W; Lin C; Guo Y; Chen Y; Du Y; Lau WB; Xia Y; Zhang F; Su R; Gao E; Wang Y; Li C; Liu R; Ma XL; Tao L
    Circ Res; 2020 Mar; 126(7):857-874. PubMed ID: 32079489
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endothelial Dysfunction in Heart Failure: What Is Its Role?
    Drera A; Rodella L; Brangi E; Riccardi M; Vizzardi E
    J Clin Med; 2024 Apr; 13(9):. PubMed ID: 38731063
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of Good Manufacturing Practice-Compatible Isolation and Culture Methods for Human Olfactory Mucosa-Derived Mesenchymal Stromal Cells.
    Kelly CJ; Lindsay SL; Smith RS; Keh S; Cunningham KT; Thümmler K; Maizels RM; Campbell JDM; Barnett SC
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255817
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mesenchymal STRO-1/STRO-3
    Sundin A; Ionescu SI; Balkan W; Hare JM
    Future Cardiol; 2023 Sep; 19(12):567-581. PubMed ID: 37933628
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insulin-like growth factor binding protein 2: a core biomarker of left ventricular dysfunction in dilated cardiomyopathy.
    Yu W; Gao H; Hu T; Tan X; Liu Y; Liu H; He S; Chen Z; Guo S; Huang J
    Hereditas; 2023 Oct; 160(1):36. PubMed ID: 37904201
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of dynamical changes in vital signs during allogeneic human umbilical cord-derived mesenchymal stem cells infusion.
    Wang Y; Yu H; Tang H; Zhu R; Shi Y; Xu C; Li Y; Wang H; Chen Y; Shen P; Xu J; Wang C; Liu Z
    Regen Ther; 2023 Dec; 24():282-287. PubMed ID: 37559872
    [TBL] [Abstract][Full Text] [Related]  

  • 34. From bedside to the bench: patient-specific hiPSC-EC models uncover endothelial dysfunction in genetic cardiomyopathies.
    Rabino M; Sommariva E; Zacchigna S; Pompilio G
    Front Physiol; 2023; 14():1237101. PubMed ID: 37538375
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intramyocardial cell-based therapy with Lomecel-B during bidirectional cavopulmonary anastomosis for hypoplastic left heart syndrome: the ELPIS phase I trial.
    Kaushal S; Hare JM; Hoffman JR; Boyd RM; Ramdas KN; Pietris N; Kutty S; Tweddell JS; Husain SA; Menon SC; Lambert LM; Danford DA; Kligerman SJ; Hibino N; Korutla L; Vallabhajosyula P; Campbell MJ; Khan A; Naioti E; Yousefi K; Mehranfard D; McClain-Moss L; Oliva AA; Davis ME
    Eur Heart J Open; 2023 Mar; 3(2):oead002. PubMed ID: 36950450
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of a growth hormone-releasing hormone agonist in a murine model of cardiometabolic heart failure with preserved ejection fraction.
    Kanashiro-Takeuchi RM; Takeuchi LM; Dulce RA; Kazmierczak K; Balkan W; Cai R; Sha W; Schally AV; Hare JM
    Am J Physiol Heart Circ Physiol; 2023 Jun; 324(6):H739-H750. PubMed ID: 36897749
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Engineering bioactive nanoparticles to rejuvenate vascular progenitor cells.
    Bui L; Edwards S; Hall E; Alderfer L; Round K; Owen M; Sainaghi P; Zhang S; Nallathamby PD; Haneline LS; Hanjaya-Putra D
    Commun Biol; 2022 Jun; 5(1):635. PubMed ID: 35768543
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of Endothelial Progenitor Cell Functions in Ischemic Heart Disease: New Therapeutic Targets for Cardiac Remodeling and Repair.
    Huang H; Huang W
    Front Cardiovasc Med; 2022; 9():896782. PubMed ID: 35677696
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Allogeneic Cell Combination Therapy Ameliorates Chronic Kidney Disease-Induced Heart Failure with Preserved Ejection Fraction.
    Rieger AC; Tompkins BA; Natsumeda M; Florea V; Banerjee MN; Rodriguez J; Rosado M; Porras V; Valasaki K; Takeuchi LM; Collon K; Desai S; Bellio MA; Khan A; Kashikar ND; Landin AM; Hardin DV; Rodriguez DA; Balkan W; Hare JM; Schulman IH
    Stem Cells Transl Med; 2022 Mar; 11(1):59-72. PubMed ID: 35641169
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and Safety of MSC Cell Therapies for Hospitalized Patients with COVID-19: A Systematic Review and Meta-Analysis.
    Qu W; Wang Z; Engelberg-Cook E; Yan D; Siddik AB; Bu G; Allickson JG; Kubrova E; Caplan AI; Hare JM; Ricordi C; Pepine CJ; Kurtzberg J; Pascual JM; Mallea JM; Rodriguez RL; Nayfeh T; Saadi S; Durvasula RV; Richards EM; March K; Sanfilippo FP
    Stem Cells Transl Med; 2022 Jul; 11(7):688-703. PubMed ID: 35640138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.